Light and laser treatment modalities for disseminated superficial actinic porokeratosis: a systematic review

Gregory A. Aird, Jenna L. Sitenga, Austin Huy Nguyen, Adam Vaudreuil, Christopher Huerter

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Treatment of disseminated superficial actinic porokeratosis (DSAP) is poorly standardized. The present review seeks to comprehensively discuss the potential for laser and light modalities in the treatment of DSAP. A systematic review of light and laser treatment modalities was conducted to include 26 cases of patients with DSAP. Systematic review resulted in 14 articles to be included. Photodynamic therapy (PDT) overall was the least successful treatment modality, with clinical improvement seen in a minority of patients (MAL-PDT: N = 9 patients, 33.3% showed improvement; ALA-PDT: N = 3 patients, 0% improvement; hypericin-PDT: N = 2 patients, 0% improvement) after numerous post-procedural side effects of hyperpigmentation, inflammation, erythema, and discomfort. Overall, in the available reports, PDT demonstrates poor outcomes with greater incidence of side effects. The response rates of DSAP lesions treated with lasers were as follows: (Q-switched ruby lasers: N = 2, 100%; CO2 laser: N = 1, 100%; PDT and CO2 combination therapy: N = 2, 0–50%; erbium and neodymium YAG lasers: N = 2, 100%; fractional 1927-nm thulium fiber lasers: N = 2, 100%; Grenz rays: N = 1, 100%; and fractional photothermolysis: N = 2, 100%). The side effects of laser therapy were minimal and included mild erythema, slight hyperpigmentation, and moderate edema. Laser therapy is a promising treatment option for DSAP with an excellent side effect profile. However, higher power studies are required to determine optimal guidelines for laser treatment of DSAP.

Original languageEnglish (US)
Pages (from-to)1-8
Number of pages8
JournalLasers in Medical Science
DOIs
StateAccepted/In press - Feb 27 2017

Fingerprint

Porokeratosis
Photochemotherapy
Lasers
Light
Hyperpigmentation
Solid-State Lasers
Laser Therapy
Erythema
Therapeutics
Thulium
Neodymium
Gas Lasers
Edema
X-Rays
Guidelines
Inflammation
Incidence

All Science Journal Classification (ASJC) codes

  • Surgery
  • Dermatology

Cite this

Light and laser treatment modalities for disseminated superficial actinic porokeratosis : a systematic review. / Aird, Gregory A.; Sitenga, Jenna L.; Nguyen, Austin Huy; Vaudreuil, Adam; Huerter, Christopher.

In: Lasers in Medical Science, 27.02.2017, p. 1-8.

Research output: Contribution to journalArticle

@article{b4aa4cc0cedd43b79e27292be8450d26,
title = "Light and laser treatment modalities for disseminated superficial actinic porokeratosis: a systematic review",
abstract = "Treatment of disseminated superficial actinic porokeratosis (DSAP) is poorly standardized. The present review seeks to comprehensively discuss the potential for laser and light modalities in the treatment of DSAP. A systematic review of light and laser treatment modalities was conducted to include 26 cases of patients with DSAP. Systematic review resulted in 14 articles to be included. Photodynamic therapy (PDT) overall was the least successful treatment modality, with clinical improvement seen in a minority of patients (MAL-PDT: N = 9 patients, 33.3{\%} showed improvement; ALA-PDT: N = 3 patients, 0{\%} improvement; hypericin-PDT: N = 2 patients, 0{\%} improvement) after numerous post-procedural side effects of hyperpigmentation, inflammation, erythema, and discomfort. Overall, in the available reports, PDT demonstrates poor outcomes with greater incidence of side effects. The response rates of DSAP lesions treated with lasers were as follows: (Q-switched ruby lasers: N = 2, 100{\%}; CO2 laser: N = 1, 100{\%}; PDT and CO2 combination therapy: N = 2, 0–50{\%}; erbium and neodymium YAG lasers: N = 2, 100{\%}; fractional 1927-nm thulium fiber lasers: N = 2, 100{\%}; Grenz rays: N = 1, 100{\%}; and fractional photothermolysis: N = 2, 100{\%}). The side effects of laser therapy were minimal and included mild erythema, slight hyperpigmentation, and moderate edema. Laser therapy is a promising treatment option for DSAP with an excellent side effect profile. However, higher power studies are required to determine optimal guidelines for laser treatment of DSAP.",
author = "Aird, {Gregory A.} and Sitenga, {Jenna L.} and Nguyen, {Austin Huy} and Adam Vaudreuil and Christopher Huerter",
year = "2017",
month = "2",
day = "27",
doi = "10.1007/s10103-017-2179-9",
language = "English (US)",
pages = "1--8",
journal = "Lasers in Medical Science",
issn = "0268-8921",
publisher = "Springer London",

}

TY - JOUR

T1 - Light and laser treatment modalities for disseminated superficial actinic porokeratosis

T2 - a systematic review

AU - Aird, Gregory A.

AU - Sitenga, Jenna L.

AU - Nguyen, Austin Huy

AU - Vaudreuil, Adam

AU - Huerter, Christopher

PY - 2017/2/27

Y1 - 2017/2/27

N2 - Treatment of disseminated superficial actinic porokeratosis (DSAP) is poorly standardized. The present review seeks to comprehensively discuss the potential for laser and light modalities in the treatment of DSAP. A systematic review of light and laser treatment modalities was conducted to include 26 cases of patients with DSAP. Systematic review resulted in 14 articles to be included. Photodynamic therapy (PDT) overall was the least successful treatment modality, with clinical improvement seen in a minority of patients (MAL-PDT: N = 9 patients, 33.3% showed improvement; ALA-PDT: N = 3 patients, 0% improvement; hypericin-PDT: N = 2 patients, 0% improvement) after numerous post-procedural side effects of hyperpigmentation, inflammation, erythema, and discomfort. Overall, in the available reports, PDT demonstrates poor outcomes with greater incidence of side effects. The response rates of DSAP lesions treated with lasers were as follows: (Q-switched ruby lasers: N = 2, 100%; CO2 laser: N = 1, 100%; PDT and CO2 combination therapy: N = 2, 0–50%; erbium and neodymium YAG lasers: N = 2, 100%; fractional 1927-nm thulium fiber lasers: N = 2, 100%; Grenz rays: N = 1, 100%; and fractional photothermolysis: N = 2, 100%). The side effects of laser therapy were minimal and included mild erythema, slight hyperpigmentation, and moderate edema. Laser therapy is a promising treatment option for DSAP with an excellent side effect profile. However, higher power studies are required to determine optimal guidelines for laser treatment of DSAP.

AB - Treatment of disseminated superficial actinic porokeratosis (DSAP) is poorly standardized. The present review seeks to comprehensively discuss the potential for laser and light modalities in the treatment of DSAP. A systematic review of light and laser treatment modalities was conducted to include 26 cases of patients with DSAP. Systematic review resulted in 14 articles to be included. Photodynamic therapy (PDT) overall was the least successful treatment modality, with clinical improvement seen in a minority of patients (MAL-PDT: N = 9 patients, 33.3% showed improvement; ALA-PDT: N = 3 patients, 0% improvement; hypericin-PDT: N = 2 patients, 0% improvement) after numerous post-procedural side effects of hyperpigmentation, inflammation, erythema, and discomfort. Overall, in the available reports, PDT demonstrates poor outcomes with greater incidence of side effects. The response rates of DSAP lesions treated with lasers were as follows: (Q-switched ruby lasers: N = 2, 100%; CO2 laser: N = 1, 100%; PDT and CO2 combination therapy: N = 2, 0–50%; erbium and neodymium YAG lasers: N = 2, 100%; fractional 1927-nm thulium fiber lasers: N = 2, 100%; Grenz rays: N = 1, 100%; and fractional photothermolysis: N = 2, 100%). The side effects of laser therapy were minimal and included mild erythema, slight hyperpigmentation, and moderate edema. Laser therapy is a promising treatment option for DSAP with an excellent side effect profile. However, higher power studies are required to determine optimal guidelines for laser treatment of DSAP.

UR - http://www.scopus.com/inward/record.url?scp=85013919123&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85013919123&partnerID=8YFLogxK

U2 - 10.1007/s10103-017-2179-9

DO - 10.1007/s10103-017-2179-9

M3 - Article

C2 - 28239750

AN - SCOPUS:85013919123

SP - 1

EP - 8

JO - Lasers in Medical Science

JF - Lasers in Medical Science

SN - 0268-8921

ER -